Transplant immunology · 2025
The regulatory mechanism of long non-coding RNAs (lncRNAs) of integrin alpha L (ITGAL) sequences (lncRNA-ITGAL) in CD4+ T cell differentiation during immune rejection of corneal transplants.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cao Qian, Li Yong, Li Yunchuan, Tan Shuang, Gao Guojun, Li Lan
Аннотация
OBJECTIVE: Corneal blindness remains a major global contributor to visual impairment, affecting approximately 6.17 million individuals. High-risk corneal transplantation is associated with rejection rates of up to 50 %, necessitating the development of new therapeutic strategies to complement or enhance conventional immunosuppressive treatments, including corticosteroids and calcineurin inhibitors. This study aimed to examine the regulatory function of long non-coding RNAs (lncRNAs) transcribed from integrin alpha L (ITGAL) sequences (lncRNA-ITGAL) in CD4+ T cell differentiation during immune rejection following corneal transplantation.
METHODS: Sprague Dawley rats (n = 20) were assigned to either a control or rejection group. Corneal rejection indices were assessed two weeks post-transplantation. Histopathological evaluation was performed using hematoxylin and eosin staining. RNA sequencing was conducted to analyze differentially expressed lncRNA and messenger RNA profiles. Flow cytometry was used to quantify Th1, Th2, and Th17 subsets in human peripheral blood mononuclear cells. Quantitative reverse transcription polymerase chain reaction was employed to measure the expression of lncRNA-ITGAL, miR-378a-3p, and tumor necrosis factor receptor-associated factor 1. Spatial interactions were examined through fluorescence in situ hybridization and immunohistochemistry.
RESULTS: Corneal tissues in the rejection group exhibited significant stromal edema and opacity (p < 0.05). RNA sequencing identified 7057 differentially expressed lncRNAs and 5485 differentially expressed mRNAs (p < 0.05). The expression of lncRNA-ITGAL was positively correlated with TRAF1 and negatively correlated with miR-378a-3p. Flow cytometry demonstrated that overexpression of lncRNA-ITGAL increased the proportions of Th1, Th2, and Th17 subsets (p < 0.05), whereas its knockdown reduced these subsets. In corneal tissues, upregulated expression of lncRNA-ITGAL and TRAF1, along with downregulated miR-378a-3p, was observed in the rejection group (p < 0.05). Immunohistochemical analysis confirmed elevated tumor necrosis factor receptor-associated factor 1 (TRAF1) expression in the corneal epithelium (p < 0.05).
CONCLUSION: lncRNA-ITGAL modulates the differentiation of Th1, Th2, and Th17 subsets through the miR-378a-3p/TRAF1 axis, highlighting its potential as a therapeutic target for improving corneal graft survival.
METHODS: Sprague Dawley rats (n = 20) were assigned to either a control or rejection group. Corneal rejection indices were assessed two weeks post-transplantation. Histopathological evaluation was performed using hematoxylin and eosin staining. RNA sequencing was conducted to analyze differentially expressed lncRNA and messenger RNA profiles. Flow cytometry was used to quantify Th1, Th2, and Th17 subsets in human peripheral blood mononuclear cells. Quantitative reverse transcription polymerase chain reaction was employed to measure the expression of lncRNA-ITGAL, miR-378a-3p, and tumor necrosis factor receptor-associated factor 1. Spatial interactions were examined through fluorescence in situ hybridization and immunohistochemistry.
RESULTS: Corneal tissues in the rejection group exhibited significant stromal edema and opacity (p < 0.05). RNA sequencing identified 7057 differentially expressed lncRNAs and 5485 differentially expressed mRNAs (p < 0.05). The expression of lncRNA-ITGAL was positively correlated with TRAF1 and negatively correlated with miR-378a-3p. Flow cytometry demonstrated that overexpression of lncRNA-ITGAL increased the proportions of Th1, Th2, and Th17 subsets (p < 0.05), whereas its knockdown reduced these subsets. In corneal tissues, upregulated expression of lncRNA-ITGAL and TRAF1, along with downregulated miR-378a-3p, was observed in the rejection group (p < 0.05). Immunohistochemical analysis confirmed elevated tumor necrosis factor receptor-associated factor 1 (TRAF1) expression in the corneal epithelium (p < 0.05).
CONCLUSION: lncRNA-ITGAL modulates the differentiation of Th1, Th2, and Th17 subsets through the miR-378a-3p/TRAF1 axis, highlighting its potential as a therapeutic target for improving corneal graft survival.